For the first time ever, SCINTIX biology-guided radiotherapy uses the emissions from the cancer itself for live targeting of tumors at any stage.
Learn more about RefleXion’s breakthrough technology.
Learn how RefleXion BgRT is being designed from the ground up to treat multiple tumors in parallel during a single session.
Learn more about RefleXion technology and what makes our machine unique.
Powered by the rapidly expanding universe of radiopharmaceuticals, the RefleXion® X1 with SCINTIX technology uses PET emissions for live targeting of tumors at any stage. Only SCINTIX therapy will leverage disease-specific radiotracers as they become available.
The RefleXion X1 is designed to deliver SCINTIX therapy along with industry-leading CT-guided IMRT and SBRT. Equipped with fan-beam kVCT imaging, RefleXion aims to reduce toxicities from radiotherapy while delivering a powerful blow to the target.
SCINTIX biology-guided radiotherapy makes definitive radiotherapy an option for patients with any stage of cancer. Our breakthrough technology expands treatment to hundreds of thousands of patients across the U.S.
Finally, SCINTIX therapy solves the conundrum of tumor tracking by using PET emissions to deliver live targeting information continuously during treatment. This approach reduces the need for motion management techniques such as gating or implanted fiducials and may result in lower toxicity to healthy tissue.
Let us tell you more.
Contact UsStay up to date.
Sign Up